#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	25862	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2012	1263.5	0	.	n	.	0	C451T	SNP	451	451	C	702	702	T	1427	T,C	763,616	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	25862	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2012	1263.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	1515	C	1468	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	25862	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2012	1263.5	0	HET	.	.	.	C207T,A	.	207	207	C	458	458	C	1494	C,T,A	1166,265,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	48274	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3552	1344.1	0	.	n	.	0	T695C	SNP	695	695	T	991	991	C	1517	C	1463	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	48274	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3552	1344.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1934	1934	G	1491	G,A,C	690,746,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	48274	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3552	1344.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2267	2267	C	1458	C,A	1383,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	48274	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3552	1344.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2341	2341	A	1461	A	1413	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	48274	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3552	1344.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2893	2893	C	1454	C	1402	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	3098	folP	855	855	100.0	folP.l15.c4.ctg.1	1564	195.2	1	SNP	p	R229S	1	.	.	685	687	AGC	974	976	AGC	290;292;293	A;G;C	277;280;280	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8288	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3366	243.4	1	SNP	p	S91F	1	.	.	271	273	TTC	582	584	TTC	277;277;279	T;T,C;C,T	264;264,1;262,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8288	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3366	243.4	1	SNP	p	D95G	1	.	.	283	285	GGC	594	596	GGC	273;272;271	G;G,T;C,T	260;262,1;262,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8288	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3366	243.4	1	SNP	p	G95N	0	.	.	283	285	GGC	594	596	GGC	273;272;271	G;G,T;C,T	260;262,1;262,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2762	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1373	199.3	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	313;315;315	G;G;C	302;301;301	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1298	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	952	134.9	0	.	n	.	0	A197.	DEL	197	197	A	587	587	A	269	A	260	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3025	254.6	1	SNP	p	D86N	0	.	.	256	258	GAC	586	588	GAC	320;319;316	G;A;C	304;300;304	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3025	254.6	1	SNP	p	R87I	0	.	.	259	261	CGT	589	591	CGT	315;313;313	C;G;T	302;297;298	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3025	254.6	1	SNP	p	R87W	0	.	.	259	261	CGT	589	591	CGT	315;313;313	C;G;T	302;297;298	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3025	254.6	1	SNP	p	S87R	1	.	.	259	261	CGT	589	591	CGT	315;313;313	C;G;T	302;297;298	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3025	254.6	1	SNP	p	S88P	0	.	.	262	264	TCC	592	594	TCC	313;311;311	T;C;C	299;296;298	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6460	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2619	244.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1483	1485	GGC	291;290;285	G;G,A;C	279;275,1;269	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1202	1204	GCC	381;381;387	G;C;C	366;374;374	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1205	1207	ATG	389;388;387	A;T,C;GAA,GA	380;377,1;371,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1217	1219	ACC	392;392;393	A;C;C	372;382;379	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1217	1219	ACC	392;392;393	A;C;C	372;382;379	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1718	1720	ACC	343;345;349	A;C,T;C,G	317;328,1;330,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1772	1774	GCG	338;341;341	G;C;G	332;330;336	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1772	1774	GCG	338;341;341	G;C;G	332;330;336	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1895	1897	GGT	308;307;303	G,T;G;T	293,1;293;288	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1904	1906	AGC	292;292;290	A,G;G;C	276,1;278;275	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7074	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2502	278.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1922	1924	CCG	223;225;223	C,G;C,G;G	200,8;200,5;199	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	9602	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3181	298.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1623	1625	CCG	343;338;336	C,T,A;C;G	315,1,1;323;314	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3316	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1957	167.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	662	662	C	245	C	226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	5128	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1280	384.0	1	SNP	p	G120K	1	.	.	358	360	AAG	479	481	AAG	402;404;402	A;A;G	385;391;381	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	5128	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1280	384.0	1	SNP	p	A121N	1	.	.	361	363	AAC	482	484	AAC	410;409;410	A,G;A,T;C,A	392,1;391,1;390,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	5128	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1280	384.0	1	SNP	p	N121D	0	.	.	361	363	AAC	482	484	AAC	410;409;410	A,G;A,T;C,A	392,1;391,1;390,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	18898	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4751	393.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	2232	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	969	226.2	1	SNP	p	V57M	1	.	.	169	171	ATG	448	450	ATG	470;473;477	A;T;G	461;463;464	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
